Ibrance : Palbociclib 125 Mg Capsules

Brand Name : Ibrance 125mg
Composition : Palbociclib
Manufactured by : Pfizer Pharmaceuticals, Inc.
Strength : 120 mg
Form : Capsules
Packing : Pack of 21 Capsules

Category:

Description

Palbociclib is an oral chemotherapy used to treat advanced breast cancer. This drug is used as part of a combination therapy. That means it is taken with other drugs. Palbociclib is generally taken in combination with letrozole

Ibrance (Palbociclip 125mg) ) is a product of Pfizer and is known as IBRANCE in other parts of the world

The drug was reviewed and approved under the Food and Drug Administration’s (FDA) accelerated Priority Review and Breakthrough Therapy designation programs on February of 2015

The drug was approved for use in the European Union in November 2016 as a treatment for hormone receptor (HR) positive, human epidermal growth factor receptor 2 (HER2) negative locally advanced or metastatic breast cancer

Palbace comes in capsule form in 125 mg dose. 1 pack has 21 capsules.

Prescription Required:

In order to legally purchase this medicine you’ll require a prescription from your Registered Medical Practitioner.

Note:

The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
Remember, keep this and all other medicines out of the reach of children and away from pets, never share your medicines with others, and use this medication only for the indication prescribed.
The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Reviews

There are no reviews yet.

Be the first to review “Ibrance : Palbociclib 125 Mg Capsules”

Your email address will not be published. Required fields are marked *